Tirzepatide, the active ingredient in the diabetes drug Mounjaro, helped people lose more than 60 pounds (lb), or at least one-quarter of their body weight, when used along with intensive ...

A new study compared the effectiveness of weight-loss drugs tirzepatide and semaglutide, finding tirzepatide leads to greater weight loss and waist reduction. Doctors shared insights.

Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.“Despite being the ...

Overall, the study found that tirzepatide was more effective at helping participants lose weight. About 82% of participants taking tirzepatide experienced 5% or greater weight loss.

A new study of the type 2 diabetes drug tirzepatide found it also resulted in dramatic weight loss, offering hope for those struggling with obesity. Karen Weintraub. USA TODAY.

People taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study. CNN values your feedback 1.

Drugmaker Eli Lilly is hoping tirzepatide, sold as Mounjaro and Zepbound for diabetes and weight loss, will become the first drug approved to treat sleep apnea, which it says affects some 80 ...

“Tirzepatide is the first investigational medicine to deliver more than 20% weight loss on average in a phase 3 study, reinforcing our confidence in its potential to help people living with ...

Overweight or obese adults are three times more likely to shed 15% of their body weight on Mounjaro than Ozempic, according to a study published Monday in the journal JAMA Internal Medicine.

New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that around two-thirds of participants of the SURMOUNT-1 trial had only regained 5% or ...

Overall, the study found that tirzepatide was more effective at helping participants lose weight. About 82% of participants taking tirzepatide experienced 5% or greater weight loss.